These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples. Berger A, Scherzed L, Stürmer M, Preiser W, Doerr HW, Rabenau HF. J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364 [Abstract] [Full Text] [Related]
4. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load. Gottesman BS, Grosman Z, Lorber M, Levi I, Shitrit P, Mileguir F, Gottesman G, Chowers MY. J Med Virol; 2004 Jun; 73(2):167-71. PubMed ID: 15122788 [Abstract] [Full Text] [Related]
6. Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays--LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5. Katsoulidou A, Petrodaskalaki M, Sypsa V, Papachristou E, Anastassopoulou CG, Gargalianos P, Karafoulidou A, Lazanas M, Kordossis T, Andoniadou A, Hatzakis A. J Virol Methods; 2006 Feb; 131(2):168-74. PubMed ID: 16194575 [Abstract] [Full Text] [Related]
7. [Comparison of NucliSens HIV-1 QT and Amplicor HIV-1 monitor 1.5 in detecting HIV-1 viral load]. Pan PL, Xu WY, Yao J, Tao XX, Pei LJ, Jiang Y. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):177-9. PubMed ID: 17653329 [Abstract] [Full Text] [Related]
8. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens. Galli R, Merrick L, Friesenhahn M, Ziermann R. J Clin Virol; 2005 Dec; 34(4):245-52. PubMed ID: 16286047 [Abstract] [Full Text] [Related]
9. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals. Taylor N, Schmid I, Egle A, Greil R, Patsch W, Oberkofler H. Antivir Ther; 2009 Dec; 14(8):1189-93. PubMed ID: 20032549 [Abstract] [Full Text] [Related]
10. Comparative performance of the Amplicor HIV-1 Monitor Assay versus NucliSens EasyQ in HIV subtype C-infected patients. Gottesman BS, Grossman Z, Lorber M, Levi I, Shitrit P, Katzir M, Shahar E, Gottesman G, Chowers M. J Med Virol; 2006 Jul; 78(7):883-7. PubMed ID: 16721845 [Abstract] [Full Text] [Related]
11. Evaluation of the NucliSens EasyQ HIV-1 v1.1 and RealTime HIV-1 kits for quantitation of HIV-1 RNA in plasma. Choi JY, Kim EJ, Rho HJ, Kim JY, Kwon OK, Lee JH, Koo MJ, Kim SS. J Virol Methods; 2009 Oct; 161(1):7-11. PubMed ID: 19576640 [Abstract] [Full Text] [Related]
12. Comparison of versions 1.0 AND 1.5 of the UltraSensitive AMPLICOR HIV-1 MONITOR test for subjects with low viral load. Jackson JB, Piwowar-Manning E, Johnson-Lewis L, Bassett R, Demeter LM, Brambilla D. J Clin Microbiol; 2004 Jun; 42(6):2774-6. PubMed ID: 15184467 [Abstract] [Full Text] [Related]
13. Discordance between viral loads determined by Roche COBAS AMPLICOR human immunodeficiency virus type 1 monitor (version 1.5) Standard and ultrasensitive assays caused by freezing patient plasma in centrifuged becton-dickinson vacutainer brand plasma preparation tubes. Salimnia H, Moore EC, Crane LR, Macarthur RD, Fairfax MR. J Clin Microbiol; 2005 Sep; 43(9):4635-9. PubMed ID: 16145119 [Abstract] [Full Text] [Related]
14. Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study. Mine M, Bedi K, Maruta T, Madziva D, Tau M, Zana T, Gaolathe T, Moyo S, Seipone K, Ndwapi N, Essex M, Marlink R. J Virol Methods; 2009 Jul; 159(1):93-7. PubMed ID: 19442851 [Abstract] [Full Text] [Related]
15. Detection of HIV type 1 load by the Roche Cobas TaqMan assay in patients with viral loads previously undetectable by the Roche Cobas Amplicor Monitor. Gatanaga H, Tsukada K, Honda H, Tanuma J, Yazaki H, Watanabe T, Honda M, Teruya K, Kikuchi Y, Oka S. Clin Infect Dis; 2009 Jan 15; 48(2):260-2. PubMed ID: 19113986 [No Abstract] [Full Text] [Related]
16. Low-level viremia associated with the use of TaqMan assay. Szabo S, Moffett LE, Cantwell-McNelis K, James CW, Joseph A. J Int Assoc Physicians AIDS Care (Chic); 2010 Jan 15; 9(4):203-5. PubMed ID: 20530465 [Abstract] [Full Text] [Related]
17. Impact of the COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR Test, Version 1.5, on clinical laboratory operations. Germer JJ, Bendel JL, Dolenc CA, Nelson SR, Masters AL, Gerads TM, Mandrekar JN, Mitchell PS, Yao JD. J Clin Microbiol; 2007 Sep 15; 45(9):3101-4. PubMed ID: 17634308 [Abstract] [Full Text] [Related]
18. Evaluation of NucliSens EasyQ HIV-1 assay for quantification of HIV-1 subtypes prevalent in South-east Asia. Lam HY, Chen JH, Wong KH, Chan K, Li P, Lee MP, Tsang DN, Yuen KY, Yam WC. J Clin Virol; 2007 Jan 15; 38(1):39-43. PubMed ID: 17110162 [Abstract] [Full Text] [Related]
19. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China. Xu S, Song A, Nie J, Li X, Meng S, Zhang C, Wang Y. J Clin Virol; 2012 Jan 15; 53(1):33-7. PubMed ID: 22051503 [Abstract] [Full Text] [Related]
20. Performance of the automated COBAS AmpliPrep/COBAS TaqMan HIV-1 test on a genetically diverse panel of specimens from China: comparison to the COBAS amplicor HIV-1 monitor test, v1.5. Xu S, Song A, Li X, Nie J, Zhang C, Wang Y. Intervirology; 2010 Jan 15; 53(4):221-8. PubMed ID: 20332651 [Abstract] [Full Text] [Related] Page: [Next] [New Search]